These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1848592)

  • 21. Characterization of Toscana virus-defective interfering particles generated in vivo.
    Marchi A; Nicoletti L; Accardi L; Di Bonito P; Giorgi C
    Virology; 1998 Jun; 246(1):125-33. PubMed ID: 9657000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Bunyamwera virus defective interfering particles.
    Patel AH; Elliott RM
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():389-96. PubMed ID: 1538195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent infection of cultured mammalian cells by Japanese encephalitis virus.
    Schmaljohn C; Blair CD
    J Virol; 1977 Nov; 24(2):580-9. PubMed ID: 916028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of a Cell Culture Model of Persistent Flaviviral Infection: Usutu Virus Shows Sustained Replication during Passages and Resistance to Extinction by Antiviral Nucleosides.
    Sempere RN; Arias A
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31212939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus.
    Colombage G; Hall R; Pavy M; Lobigs M
    Virology; 1998 Oct; 250(1):151-63. PubMed ID: 9770429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment and maintenance of persistent infection by the Phlebovirus Toscana in Vero cells.
    Verani P; Nicoletti L; Marchi A
    J Gen Virol; 1984 Feb; 65 ( Pt 2)():367-75. PubMed ID: 6693858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus.
    Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-mediated persistent infection of Saint Louis encephalitis virus in a reptilian cell line.
    Mathews JH; Vorndam AV
    J Gen Virol; 1982 Aug; 61 (Pt 2)():177-86. PubMed ID: 6181191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of immobilised Murray Valley encephalitis virus RNA using oligonucleotide probes with varying degrees of mismatch.
    Howard MJ; Coelen RJ; Mackenzie JS
    J Virol Methods; 1991 Oct; 34(3):333-41. PubMed ID: 1660491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute and chronic Lassa virus infection of Vero cells].
    Lukashevich IS; Mar'iankova RF; Fidarov FM
    Vopr Virusol; 1981; (4):452-6. PubMed ID: 7303630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic analysis of poliovirus protein 3A: characterization of a non-cytopathic mutant virus defective in killing Vero cells.
    Lama J; Sanz MA; Carrasco L
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1911-21. PubMed ID: 9714239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent infection of MDCK cells by influenza C virus: initiation and characterization.
    Goshima FY; Maeno K
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3481-5. PubMed ID: 2481713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of defective interfering particles in persistent infection of Vero cells by measles virus.
    Rima BK; Davidson WB; Martin SJ
    J Gen Virol; 1977 Apr; 35(1):89-97. PubMed ID: 404394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mouse-attenuated envelope protein variant of Murray Valley encephalitis virus with altered fusion activity.
    McMinn PC; Weir RC; Dalgarno L
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2085-8. PubMed ID: 8811007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An amino acid change in the non-structural NS2 protein of an influenza A virus mutant is responsible for the generation of defective interfering (DI) particles by amplifying DI RNAs and suppressing complementary RNA synthesis.
    Odagiri T; Tominaga K; Tobita K; Ohta S
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():43-53. PubMed ID: 8113739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence.
    Lobigs M; Usha R; Nestorowicz A; Marshall ID; Weir RC; Dalgarno L
    Virology; 1990 Jun; 176(2):587-95. PubMed ID: 2161151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic differentiation of Murray Valley encephalitis virus in Australia and Papua New Guinea.
    Lobigs M; Marshall ID; Weir RC; Dalgarno L
    Aust J Exp Biol Med Sci; 1986 Dec; 64 ( Pt 6)():571-85. PubMed ID: 2884985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and E protein expression of mutant strains during persistent infection of KN73 cells with Japanese encephalitis virus.
    Feng G; Takegami T; Zhao G
    Chin Med J (Engl); 2002 Sep; 115(9):1324-7. PubMed ID: 12411104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenic structure of the Murray Valley encephalitis virus E glycoprotein.
    Hawkes RA; Roehrig JT; Hunt AR; Moore GA
    J Gen Virol; 1988 May; 69 ( Pt 5)():1105-9. PubMed ID: 2453607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA synthesis in the L cell-SV5 system.
    Azadova NB; Zhdanov VM
    Acta Virol; 1982 Dec; 26(6):427-31. PubMed ID: 6132537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.